FI961440A - Cellinjer som avsöndrar insulin, framställningsförfaranden och användning - Google Patents
Cellinjer som avsöndrar insulin, framställningsförfaranden och användning Download PDFInfo
- Publication number
- FI961440A FI961440A FI961440A FI961440A FI961440A FI 961440 A FI961440 A FI 961440A FI 961440 A FI961440 A FI 961440A FI 961440 A FI961440 A FI 961440A FI 961440 A FI961440 A FI 961440A
- Authority
- FI
- Finland
- Prior art keywords
- pct
- cell line
- insulin
- sec
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9311687A FR2710654B1 (fr) | 1993-09-30 | 1993-09-30 | Nouvelles lignées de cellules sécrétrices d'insuline, leurs procédés d'obtention par voie de manipulation génétique et leur utilisation chez des sujets diabétiques sous forme protégée. |
PCT/FR1994/001129 WO1995009231A1 (fr) | 1993-09-30 | 1994-09-27 | Lignees de cellules secretrices d'insuline, procedes d'obtention et utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
FI961440A true FI961440A (sv) | 1996-03-29 |
FI961440A0 FI961440A0 (sv) | 1996-03-29 |
Family
ID=9451437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI961440A FI961440A0 (sv) | 1993-09-30 | 1996-03-29 | Cellinjer som avsöndrar insulin, framställningsförfaranden och användning |
Country Status (17)
Country | Link |
---|---|
US (1) | US5902577A (sv) |
EP (1) | EP0721500B1 (sv) |
JP (2) | JPH09503662A (sv) |
KR (2) | KR100463366B1 (sv) |
CN (1) | CN1078248C (sv) |
AT (1) | ATE299930T1 (sv) |
AU (1) | AU688383B2 (sv) |
BR (1) | BR9407682A (sv) |
CA (1) | CA2172997A1 (sv) |
DE (1) | DE69434433T2 (sv) |
DK (1) | DK0721500T3 (sv) |
ES (1) | ES2243929T3 (sv) |
FI (1) | FI961440A0 (sv) |
FR (1) | FR2710654B1 (sv) |
HU (1) | HU219826B (sv) |
NO (1) | NO317236B1 (sv) |
WO (1) | WO1995009231A1 (sv) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5744327A (en) * | 1990-02-20 | 1998-04-28 | Board Of Regents, The University Of Texas System | Methods for producing insulin in response to non-glucose secretagogues |
US5427940A (en) * | 1991-06-03 | 1995-06-27 | Board Of Regents, The University Of Texas System | Engineered cells producing insulin in response to glucose |
US5792656A (en) * | 1991-06-03 | 1998-08-11 | Board Of Regents, The University Of Texas System | Methods of preparing genetically engineered cells that produce insulin in response to glucose |
US6642003B2 (en) | 2001-08-02 | 2003-11-04 | Cedars-Sinai Medical Center | Human glucose-dependent insulin-secreting cell line |
US7033831B2 (en) * | 2001-12-07 | 2006-04-25 | Geron Corporation | Islet cells from human embryonic stem cells |
US7141240B2 (en) * | 2002-03-12 | 2006-11-28 | Cedars-Sinai Medical Center | Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1 |
US8415153B2 (en) | 2006-06-19 | 2013-04-09 | Geron Corporation | Differentiation and enrichment of islet-like cells from human pluripotent stem cells |
US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
CN109957539A (zh) * | 2017-12-14 | 2019-07-02 | 深圳先进技术研究院 | 一种人造胰岛组织及其制备和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4229526B4 (de) * | 1992-09-07 | 2006-02-16 | Schrezenmeir, Jürgen, Dr. | Vorrichtung zur Aufnahme und zum Einbringen von biologisch aktiven Geweben oder Zellen in den menschlichen Körper |
-
1993
- 1993-09-30 FR FR9311687A patent/FR2710654B1/fr not_active Expired - Fee Related
-
1994
- 1994-09-27 JP JP7510148A patent/JPH09503662A/ja active Pending
- 1994-09-27 BR BR9407682A patent/BR9407682A/pt not_active Application Discontinuation
- 1994-09-27 EP EP94928920A patent/EP0721500B1/fr not_active Expired - Lifetime
- 1994-09-27 CA CA002172997A patent/CA2172997A1/en not_active Abandoned
- 1994-09-27 DE DE69434433T patent/DE69434433T2/de not_active Expired - Lifetime
- 1994-09-27 ES ES94928920T patent/ES2243929T3/es not_active Expired - Lifetime
- 1994-09-27 KR KR10-2004-7001293A patent/KR100463366B1/ko not_active IP Right Cessation
- 1994-09-27 AU AU78157/94A patent/AU688383B2/en not_active Ceased
- 1994-09-27 DK DK94928920T patent/DK0721500T3/da active
- 1994-09-27 CN CN94193910A patent/CN1078248C/zh not_active Expired - Fee Related
- 1994-09-27 US US08/619,612 patent/US5902577A/en not_active Expired - Lifetime
- 1994-09-27 WO PCT/FR1994/001129 patent/WO1995009231A1/fr active IP Right Grant
- 1994-09-27 KR KR1019960701650A patent/KR100432851B1/ko not_active IP Right Cessation
- 1994-09-27 AT AT94928920T patent/ATE299930T1/de not_active IP Right Cessation
- 1994-09-27 HU HU9600789A patent/HU219826B/hu not_active IP Right Cessation
-
1996
- 1996-03-29 NO NO19961268A patent/NO317236B1/no unknown
- 1996-03-29 FI FI961440A patent/FI961440A0/sv not_active Application Discontinuation
-
2005
- 2005-03-10 JP JP2005066427A patent/JP2005185293A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0721500A1 (fr) | 1996-07-17 |
HU219826B (hu) | 2001-08-28 |
NO961268D0 (no) | 1996-03-29 |
EP0721500B1 (fr) | 2005-07-20 |
DE69434433T2 (de) | 2006-04-20 |
HU9600789D0 (en) | 1996-05-28 |
FR2710654B1 (fr) | 1995-12-22 |
FI961440A0 (sv) | 1996-03-29 |
FR2710654A1 (fr) | 1995-04-07 |
AU7815794A (en) | 1995-04-18 |
KR20040017357A (ko) | 2004-02-26 |
KR100432851B1 (ko) | 2004-11-06 |
US5902577A (en) | 1999-05-11 |
HUT75985A (en) | 1997-05-28 |
CN1078248C (zh) | 2002-01-23 |
JPH09503662A (ja) | 1997-04-15 |
AU688383B2 (en) | 1998-03-12 |
JP2005185293A (ja) | 2005-07-14 |
CA2172997A1 (en) | 1995-04-06 |
ATE299930T1 (de) | 2005-08-15 |
NO317236B1 (no) | 2004-09-27 |
CN1134724A (zh) | 1996-10-30 |
WO1995009231A1 (fr) | 1995-04-06 |
NO961268L (no) | 1996-03-29 |
BR9407682A (pt) | 1997-02-04 |
ES2243929T3 (es) | 2005-12-01 |
KR960705028A (ko) | 1996-10-09 |
KR100463366B1 (ko) | 2004-12-29 |
DE69434433D1 (de) | 2005-08-25 |
DK0721500T3 (da) | 2005-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bearzi et al. | PlGF–MMP9-engineered iPS cells supported on a PEG–fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium | |
Harris et al. | The potential of cord blood stem cells for use in regenerative medicine | |
Harris | Non‐haematological uses of cord blood stem cells | |
AU2369595A (en) | In vitro growth of functional islets of langerhans and in vivo uses thereof | |
WO2004016747A3 (en) | Bone marrow cell differentiation | |
ATE270323T1 (de) | Zusammensetzungen und verfahren zur stimulierung der proliferation und der differenzierung von menschlichen fetalen und erwachsenen pankreatischen zellen ex vivo | |
ATE297169T1 (de) | Auffindbare künstliche bioimplantate | |
FI961440A (sv) | Cellinjer som avsöndrar insulin, framställningsförfaranden och användning | |
ATE320483T1 (de) | Isolierung und züchtung von schwannzellen | |
WO2003072728A3 (en) | Cellular trans-differentiation | |
Klinger et al. | Relevance and safety of telomerase for human tissue engineering | |
Komatsu et al. | A subcutaneous pancreatic islet transplantation platform using a clinically applicable, biodegradable Vicryl mesh scaffold‐an experimental study | |
Wenger et al. | Matrix remodeling expression in anulus cells subjected to increased compressive load | |
CA2488414A1 (en) | Primary cultured adipocytes for gene therapy | |
WO1986001530A1 (en) | A process for proliferation of wholly or partially differentiated beta-cellls | |
El-Sabbagh | Modern trends in lipomodeling | |
ATE341630T1 (de) | Verwendung von pankreatischer procarboxypeptidase b zur herstellung von insulin | |
Steenhuis et al. | Osteogenic and adipogenic cell fractions isolated from postnatal mouse calvaria | |
Oberholzer et al. | β Cell Replacement for the Treatment of Diabetes | |
NO951074L (no) | Levering av proteiner ved transmembran overföring for fortilpasning av xenogenetiske organtransplantat og andre hensikter | |
Woodard et al. | Re: measurement of chimerism after hematopoietic stem cell transplantation | |
Matsumoto et al. | Allogeneic Islet Transplantation and Future | |
House et al. | Effect of serial transplantation on the growth of neonatal pancreas in the hamster | |
EP0328420A3 (en) | Gangliosides containing de-n-acetyl-sialic acid and their applications as modifiers of cell physiology | |
Rajan | Insulin and Glucagon Secretion In Vitro |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |